Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Tka Assay for CDK4/6i

ClinicalTrials.gov ID: NCT06572800

Public ClinicalTrials.gov record NCT06572800. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 6:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Use of DiviTum-TKa as a Biomarker Assay for CDK4/6 Inhibitor Medication Compliance and Drug-Drug Interaction Assessment in ER/PR Positive Metastatic Breast Cancer

Study identification

NCT ID
NCT06572800
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Yale University
Other
Enrollment
34 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 4, 2023
Primary completion
Sep 15, 2025
Completion
Sep 15, 2025
Last update posted
Oct 7, 2025

2023 – 2025

United States locations

U.S. sites
18
U.S. states
2
U.S. cities
16
Facility City State ZIP Site status
Smilow Cancer Hospital-Derby Care Center Derby Connecticut 06418
Smilow Cancer Hospital Care Center-Fairfield Fairfield Connecticut 06824
Smilow Cancer Hospital Care Center at Glastonbury Glastonbury Connecticut 06033
Smilow Cancer Hospital Care Center at Greenwich Greenwich Connecticut 06830
Smilow Cancer Hospital Care Center - Guilford Guilford Connecticut 06437
Smilow Cancer Hospital-Hamden Care Center Hamden Connecticut 06518
Smilow Cancer Hospital Care Center at Saint Francis Hartford Connecticut 06105
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510
Yale-New Haven Hospital Saint Raphael Campus New Haven Connecticut 06511
Yale University New Haven Connecticut 06520
Yale-New Haven Hospital North Haven Medical Center North Haven Connecticut 06473
Smilow Cancer Hospital-Orange Care Center Orange Connecticut 06477
Smilow Cancer Hospital Care Center at Long Ridge Stamford Connecticut 06902
Smilow Cancer Hospital-Torrington Care Center Torrington Connecticut 06790
Smilow Cancer Hospital Care Center-Trumbull Trumbull Connecticut 06611
Smilow Cancer Hospital-Waterbury Care Center Waterbury Connecticut 06708
Smilow Cancer Hospital Care Center - Waterford Waterford Connecticut 06385
Smilow Cancer Hospital Care Center - Westerly Westerly Rhode Island 02891

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06572800, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06572800 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →